Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
Monthly archive
August 2010
News
The Dangers Of Information Restrictions On Drugs’ Off-Label Uses
Forbes
FDA
off-label
»
54 comments
News
What does your CEO think about Pharmaceutical Sales Representatives?
Pharmareform
drug reps
Pharma CEOs
»
50 comments
News
Why Roche Employees Will Pay With Their Jobs for Cancer Drug Avastin’s Success
BNET Pharma
Avastin
cancer
layoffs
Roche
»
51 comments
News
Genzyme for sale at right price, says CEO
Marketwatch
Genzyme
Henri Termeer
M&A
Sanofi
»
50 comments
News
Catalyst for Pfizer and Bristol Expected in 2011
Minyanville
Apixaban
Bristol-Myers Squibb
Pfizer
»
49 comments
News
J&J's Latest Recalls Cloud Outlook
TheStreet.com
DePuy
JNJ
recalls
»
34 comments
News
Why Amgen Should Buy Genzyme
Forbes
Amgen
Genzyme
M&A
Sanofi
»
40 comments
News
Halozyme preps for FDA meeting on recalled drug
Fierce Pharma
Baxter International
FDA
Halozyme
Hylenex
recalls
»
40 comments
News
9 Biotech Penny Stocks to Buy
TheStreet.com
Athersys
AVI BioPharma
Catalyst
Cyclacel
DUSA pharmaceuticals
Inhibitex
Luna Innovations
Neuralstem
Rexahn
»
42 comments
News
Dynavax gets grant for hepatitis B work
Bizjournals.com
Dynavax
grants
hepatitis B
»
36 comments
1
2
3
4
5
6
7
8
9
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT